Literature DB >> 30720930

The difference in nasal bacterial microbiome diversity between chronic rhinosinusitis patients with polyps and a control population.

Weigang Gan1,2, Fengjuan Yang1, Yiping Tang3, Danmei Zhou2, Di Qing4, Juanjuan Hu1, Shixi Liu1, Feng Liu1, Juan Meng1.   

Abstract

BACKGROUND: Little is known regarding the role of the microbiome of the paranasal sinuses and its contribution to sinus mucosal health and disease. Consequently, we examined the microbiome of chronic rhinosinusitis patients with polyps (CRSwNP) and a control population to provide new insights into the microbiota associated with the pathogenesis of CRSwNP.
METHODS: Fifty-nine CRSwNP patients and 27 controls were enrolled in the study. The bacterial communities of the middle meatus were detected using 16S ribosomal RNA (rRNA)-targeted Illumina MiSeq sequencing after microbial DNA was extracted from swabs.
RESULTS: Although there was no difference in diversity between the 2 groups, richness was lower in the CRSwNP group than in the control group (p = 0.03). At the phylum level, Firmicutes, Proteobacteria, Actinobacteria, and Bacteroidetes were predominant in both groups; however, the relative abundance was different, with the proportions of Actinobacteria (predominantly Corynebacterium) and Dolosigranulum being significantly higher in the control group than in the CRSwNP group.
CONCLUSION: These results support the theory of microbial dysbiosis as the pathogenesis of CRSwNP. The reduction in the proportions of potentially protective bacteria may decrease the overall stability of the sinonasal bacterial community.
© 2019 ARS-AAOA, LLC.

Entities:  

Keywords:  16S rRNA; 16S sequencing; bacteria; chronic rhinosinusitis; microbiome; nasal polyps

Mesh:

Substances:

Year:  2019        PMID: 30720930     DOI: 10.1002/alr.22297

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  5 in total

1.  Comparing the nasal bacterial microbiome diversity of allergic rhinitis, chronic rhinosinusitis and control subjects.

Authors:  Weigang Gan; Fengjuan Yang; Juan Meng; Feng Liu; Shixi Liu; Junming Xian
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-08-28       Impact factor: 2.503

2.  The association between chronic rhinosinusitis and proton pump inhibitor use: a nested case-control study using a health screening cohort.

Authors:  Hyo Geun Choi; Il Gyu Kong
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

3.  Dolosigranulum pigrum Cooperation and Competition in Human Nasal Microbiota.

Authors:  Silvio D Brugger; Sara M Eslami; Melinda M Pettigrew; Isabel F Escapa; Matthew T Henke; Yong Kong; Katherine P Lemon
Journal:  mSphere       Date:  2020-09-09       Impact factor: 4.389

Review 4.  Influence of the Microbiome on Chronic Rhinosinusitis With and Without Polyps: An Evolving Discussion.

Authors:  Kyle S Huntley; Joshua Raber; Lauren Fine; Jonathan A Bernstein
Journal:  Front Allergy       Date:  2021-10-01

Review 5.  The Role of Upper Airway Microbiome in the Development of Adult Asthma.

Authors:  Purevsuren Losol; Jun-Pyo Choi; Sae-Hoon Kim; Yoon-Seok Chang
Journal:  Immune Netw       Date:  2021-06-29       Impact factor: 6.303

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.